Welcome : Guest

Forward Pharma A/S (Denmark) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Forward Pharma A/S, which is principally involved in Biopharmaceuticals Business. Illustrated with 10 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64403
Price: $500
Company Type: Public
Pages: 12
Date: January 2016
Market Data Tables: 10

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Multiple Sclerosis......3
Table 1: Multiple Sclerosis Disease Occurrence by Type Worldwide (2014) - Percentage Breakdown by Volume for Begin MS, Primary Progressive MS, Relapsing-Remiting MS, and Secondary Progressive MS......3
Table 2: Multiple Sclerosis Patient Care Expenditure by Category Worldwide (2014) - Percentage Breakdown by Value for Adaptations, Ambulatory Care, Disease Modifying Drugs, Early Retirement, Hospital Inpatient Care, Informal Care, Prescription and OTC Drugs, Services, Sick-leave and Redused Working Time, and Tests......4
Table 3: No. of Tcelna (Imilecleucel-T) Secondary Progressive Multiple Sclerosis Patients by Category in the US (2014) - Percentage Breakdown for Primary Progressive MS Patients, Relapsing-Remitting MS Patients, and Secondary-Progressive MS Patients......5
Table 4: Therapeutic Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......6
Table 5: Speciality Pharmaceuticals Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......7
Relapsing-Remitting Multiple Sclerosis (RRMS)......8
Table 6: Relapsing-Remitting Multiple Sclerosis (RRMS) Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume for European Union (EU), US, Rest of World (RoW)......8
Multiple Sclerosis Therapeutics......9
Table 7: Market Shares of Leading Multiple Sclerosis Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Biogen Idec, Novartis AG, Sanofi S.A., and Others......9
Table 8: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......10
Relapsing-Remitting Multiple Sclerosis (RRMS)......11
Table 9: Market Shares of Leading Drug Brands for Relapsing-Remitting Multiple Sclerosis (RRMS) Worldwide (2015) - Percentage Breakdown by No. of Patients for Avonex, Betaseron, Copaxone, Gilenya, Laquinimod, Rebif, Tysabri, and Others......11
Table 10: Market Shares of Leading Drug Brands for Relapsing-Remitting Multiple Sclerosis (RRMS) Worldwide (2015) - Percentage Breakdown by Value for Avonex, Betaseron, Copaxone, Gilenya, Laquinimod, Rebif, Tysabri, and Others......12